ArticleBlood2025

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.

Surbhi Sidana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.